Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.

Boll D, Verhoeven RH, van der Aa MA, Pauwels P, Karim-Kos HE, Coebergh JW, van Doorn HC.

Int J Gynecol Cancer. 2012 May;22(4):599-606. doi: 10.1097/IGC.0b013e318244cedc.

PMID:
22398706
2.

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

Nordal RR, Thoresen SO.

Eur J Cancer. 1997 May;33(6):907-11.

PMID:
9291814
3.

Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.

Gao Y, Meng H, Zhang Y, Jiao T, Hui N.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1616-24. eCollection 2014.

4.

Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.

Bansal N, Herzog TJ, Seshan VE, Schiff PB, Burke WM, Cohen CJ, Wright JD.

Obstet Gynecol. 2008 Jul;112(1):64-70. doi: 10.1097/AOG.0b013e318176157c.

PMID:
18591309
5.

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I.

Gynecol Oncol. 2005 Aug;98(2):274-80.

PMID:
15972232
6.

Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.

Kellert IM, Botterweck AA, Huveneers JA, Dirx MJ.

Eur J Cancer Prev. 2009 Feb;18(1):85-9. doi: 10.1097/CEJ.0b013e3282b6fdf9.

PMID:
19077569
7.

Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.

Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA.

Gynecol Oncol. 2006 Dec;103(3):948-51. Epub 2006 Jul 25.

PMID:
16870239
8.

Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study.

Boll D, Karim-Kos HE, Verhoeven RH, Burger CW, Coebergh JW, van de Poll-Franse LV, van Doorn HC.

Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):209-14. doi: 10.1016/j.ejogrb.2012.10.028. Epub 2012 Nov 22.

PMID:
23176760
9.

Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.

Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG.

Obstet Gynecol. 2015 Jun;125(6):1362-70. doi: 10.1097/AOG.0000000000000866.

PMID:
26000507
10.

Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.

Klint A, Tryggvadóttir L, Bray F, Gislum M, Hakulinen T, Storm HH, Engholm G.

Acta Oncol. 2010 Jun;49(5):632-43. doi: 10.3109/02841861003691945.

PMID:
20307243
11.

Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.

Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE; Comprehensive Cancer Centers TAMARISK-group.

Breast Cancer Res Treat. 2008 Nov;112(1):99-108. Epub 2007 Dec 7.

PMID:
18064567
12.

Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.

de Jong RA, Nijman HW, Wijbrandi TF, Reyners AK, Boezen HM, Hollema H.

Mod Pathol. 2011 Oct;24(10):1368-79. doi: 10.1038/modpathol.2011.88. Epub 2011 May 13.

13.

Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.

Zhang C, Hu W, Jia N, Li Q, Hua K, Tao X, Wang L, Feng W.

Int J Gynecol Cancer. 2015 May;25(4):629-36. doi: 10.1097/IGC.0000000000000350.

PMID:
25633654
14.

The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Cosio S, Tisi G, Lissoni A, Ferrero AM, Cristofani R.

Eur J Gynaecol Oncol. 2002;23(4):295-9.

PMID:
12214727
15.

Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.

Page BR, Pappas L, Cooke EW, Gaffney DK.

Int J Gynecol Cancer. 2012 May;22(4):593-8. doi: 10.1097/IGC.0b013e3182412ebd.

PMID:
22343970
16.

[Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].

Wei KR, Chen WQ, Zhang SW, Zheng RS, Wang YN, Liang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jun;47(6):445-51. Chinese.

PMID:
22932112
17.

Prognostic significance of fallopian tube cytology: a study of 99 endometrial malignancies.

Mulvany NJ, Arnstein MB, Ryan VA.

Pathology. 2000 Feb;32(1):5-9.

PMID:
10740797
18.

Uterine carcinosarcomas: incidence and trends in management and survival.

Arrastia CD, Fruchter RG, Clark M, Maiman M, Remy JC, Macasaet M, Gates EJ, Di Maio T, Marzec T.

Gynecol Oncol. 1997 Apr;65(1):158-63.

PMID:
9103406
19.

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

Matthews RP, Hutchinson-Colas J, Maiman M, Fruchter RG, Gates EJ, Gibbon D, Remy JC, Sedlis A.

Gynecol Oncol. 1997 May;65(2):206-12.

PMID:
9159326

Supplemental Content

Support Center